Measuring Tumor Succinate and Fumarate to Resolve Pathogenicity of an SDHA Variant.

MLA

Davidoff, Dahlia F., et al. “Measuring Tumor Succinate and Fumarate to Resolve Pathogenicity of an SDHA Variant.” Clinical Chemistry, vol. 67, no. 4, Mar. 2021, pp. 696–99. EBSCOhost, https://doi.org/10.1093/clinchem/hvab004.

APA

Davidoff, D. F., Luxford, C., Kim, E., Novos, T., Horvath, A. R., Gill, A. J., Dwight, T., Clifton-Bligh, R. J., & Burgess, J. R. (2021). Measuring Tumor Succinate and Fumarate to Resolve Pathogenicity of an SDHA Variant. Clinical Chemistry, 67(4), 696–699. https://doi.org/10.1093/clinchem/hvab004

Chicago

Davidoff, Dahlia F, Catherine Luxford, Edward Kim, Talia Novos, Andrea R Horvath, Anthony J Gill, Trisha Dwight, Roderick J Clifton-Bligh, and John R Burgess. 2021. “Measuring Tumor Succinate and Fumarate to Resolve Pathogenicity of an SDHA Variant.” Clinical Chemistry 67 (4): 696–99. doi:10.1093/clinchem/hvab004.